Epilepsy girl’s family in cannabis treatment pleaDan Kamashu
Fundraising plea after Telford girl’s epilepsy diagnosis.
Last summer, six-year-old Sienna started to struggle to process things that were said, according to her mother Lucy Richardson
The family of a six-year-old girl are trying to raise £15,000 for a cannabis-based treatment after she was diagnosed with a rare form of epilepsy.
Sienna Richardson was found to have Landau Kleffner syndrome after showing problems with her communication skills.
Her family, from Telford, believe medicinal cannabis oil Bedrolite offers the best outcome, but have been told it is not available to Sienna on the NHS.
They hope to raise enough for 12 months worth of treatment in the Netherlands.
Sienna’s mother, Lucy, said her daughter, who had previously “excelled” at school, stopped responding to instructions or her name last summer, and initially they thought there may be problems with her hearing.
Hearing tests and an MRI showed no problems but the family was sure something was wrong.
An electroencephalogram (EEG) test initially diagnosed her with focal epilepsy, but when the treatment made her worse, the “heartbreaking” new diagnosis was made and Sienna was sent to Alder Hey Children’s Hospital in Merseyside.
Sienna has been treated at Alder Hey Children’s Hospital
Steroid treatments have not been successful, and while surgery would be an option, it could leave Sienna with paralysis of her left side.
If untreated, she could have permanent speech and language difficulties.
Through research, the family found out about Bedrolite, a medical cannabis oil made by Bedrocan, which is the sole supplier of medicinal cannabis to the Dutch government’s Office for Medicinal Cannabis.
On 1 November 2018, cannabis medicines were moved in the UK from Schedule 1 of the Misuse of Drugs Regulations, meaning they have no therapeutic value, to Schedule 2, to recognise there was conclusive evidence of benefit for some patients.
From that date, specialist doctors were allowed to prescribe cannabis medicines “where there is an unmet clinical need”.
- Faster access to cannabis medicines in UK
- Families protest over NHS medical cannabis rules
- Cannabis goods ‘could be off the shelves in a year’
But despite the law change, some families have been unable to get a prescription on the NHS.
And although it has been prescribed privately to some at Portland Hospital in London, the family said they were told there was no space for Sienna to be treated there.
Within 24 hours of launching their appeal, Sienna’s family had raised more than £2,000 towards taking her to the Netherlands for treatment.
Thousands of pounds have already been raised towards Sienna’s treatment
“We’re overwhelmed with support we have had, not just for the fundraising, but over the last six months,” Mrs Richardson said.
“We were anxious about putting it out there but it is support we need at moment…. we have got to do it for Sienna.”
An NHS spokesperson said: “The decision to prescribe medicinal cannabis is ultimately a clinical decision for specialist hospital doctors, made with patients and their families.”
Creative Commons Disclosure
About Mandatory Compliance
Mandatory Compliance is the leading UK provider of CPDUK accredited healthcare and social care training courses, e-learning programs and Ofqual approved qualifications.
Click on the links below to find out more about our accredited e-learning courses and qualifications:
- Business Administration
- Charities and Volunteers
- Child Care Services
- Clinical Commissioning Groups
- Clinical Governance
- Clinical Skills Development
- Corporate Governance
- CQC Compliance
- Education and Training
- Equality and Diversity
- FE Colleges And Universities
- Finance Management
- Health and Safety at Work – Online Training Courses
- Health & Social Care
- Health Law and Ethics
- Human Resource Management
- Information Governance (GDPR)
- IT and Technology Management
- Leadership and Management
- Local Authorities
- Long Term Conditions
- Mental Health Awareness
- Primary Care Services
- Public Health
- Research and Development
- Risk Management
- Safeguarding People at Risk
- Sales and Marketing
- Statutory Mandatory Training
- Work Skills and Development
- Workforce Development.
Contact our Support Team on 02476100090 or via Email for more courses relating to the Care Quality Commission (CQC) and other regulatory compliance requirements.